194 related articles for article (PubMed ID: 35918472)
1. Sorbitan Monolaurate-Containing Liposomes Enhance Skin Cancer Cell Cytotoxicity and in Association with Microneedling Increase the Skin Penetration of 5-Fluorouracil.
Crisóstomo LCCF; Carvalho GSG; Leal LKAM; de Araújo TG; Nogueira KAB; da Silva DA; de Oliveira Silva Ribeiro F; Petrilli R; Eloy JO
AAPS PharmSciTech; 2022 Aug; 23(6):212. PubMed ID: 35918472
[TBL] [Abstract][Full Text] [Related]
2. Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells.
Petrilli R; Eloy JO; Lopez RF; Lee RJ
Anticancer Agents Med Chem; 2017; 17(2):301-308. PubMed ID: 27225449
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection.
Petrilli R; Eloy JO; Saggioro FP; Chesca DL; de Souza MC; Dias MVS; daSilva LLP; Lee RJ; Lopez RFV
J Control Release; 2018 Aug; 283():151-162. PubMed ID: 29864476
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
5. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation.
Hussain A; Samad A; Ramzan M; Ahsan MN; Ur Rehman Z; Ahmad FJ
Drug Deliv; 2016 May; 23(4):1115-29. PubMed ID: 25379805
[TBL] [Abstract][Full Text] [Related]
6. Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line.
Yaman Ü; Aslan M; Ozturk S; Ulubayram K; Eroğlu İ
Pharm Dev Technol; 2020 Dec; 25(10):1192-1203. PubMed ID: 32729757
[TBL] [Abstract][Full Text] [Related]
7. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study.
Khan MA; Pandit J; Sultana Y; Sultana S; Ali A; Aqil M; Chauhan M
Drug Deliv; 2015; 22(6):795-802. PubMed ID: 24735246
[TBL] [Abstract][Full Text] [Related]
8. Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert: part II.
Hussain A; Haque MW; Singh SK; Ahmed FJ
Drug Deliv; 2016 May; 23(4):1242-53. PubMed ID: 26697777
[TBL] [Abstract][Full Text] [Related]
9. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer.
Paolino D; Cosco D; Muzzalupo R; Trapasso E; Picci N; Fresta M
Int J Pharm; 2008 Apr; 353(1-2):233-42. PubMed ID: 18191509
[TBL] [Abstract][Full Text] [Related]
10. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer.
Smith T; Affram K; Nottingham EL; Han B; Amissah F; Krishnan S; Trevino J; Agyare E
Sci Rep; 2020 Oct; 10(1):16989. PubMed ID: 33046724
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.
Alanazi SA; Harisa GI; Badran MM; Alanazi FK; Elzayat E; Alomrani AH; Al Meanazel OT; Al Meanazel AT
Bioengineered; 2021 Dec; 12(1):914-926. PubMed ID: 33678142
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal Composition.
Alanazi SA; Harisa GI; Badran MM; Haq N; Radwan AA; Kumar A; Shakeel F; Alanazi FK
Curr Drug Deliv; 2020; 17(10):898-910. PubMed ID: 32072911
[TBL] [Abstract][Full Text] [Related]
13. Deformable liposomes as enhancer of caffeine penetration through human skin in a Franz diffusion cell test.
Abd E; Gomes J; Sales CC; Yousef S; Forouz F; Telaprolu KC; Roberts MS; Grice JE; Lopes PS; Leite-Silva VR; Andréo-Filho N
Int J Cosmet Sci; 2021 Feb; 43(1):1-10. PubMed ID: 32866296
[TBL] [Abstract][Full Text] [Related]
14. Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation.
Calienni MN; Temprana CF; Prieto MJ; Paolino D; Fresta M; Tekinay AB; Alonso SDV; Montanari J
Drug Deliv Transl Res; 2018 Jun; 8(3):496-514. PubMed ID: 29288359
[TBL] [Abstract][Full Text] [Related]
15. Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and ex vivo studies.
Sahu P; Kashaw SK; Jain S; Sau S; Iyer AK
J Control Release; 2017 May; 253():122-136. PubMed ID: 28322977
[TBL] [Abstract][Full Text] [Related]
16. Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake.
Wenande E; Olesen UH; Nielsen MM; Janfelt C; Hansen SH; Anderson RR; Haedersdal M
Expert Opin Drug Deliv; 2017 Mar; 14(3):307-317. PubMed ID: 27835937
[TBL] [Abstract][Full Text] [Related]
17. Nanoencapsulation of Methylene-Blue for Enhanced Skin Cancer Cell Phototoxicity and Cutaneous Penetration in Association with Sonophoresis.
Soares Lima T; Silva de Oliveira MS; Reis AVF; Petrilli R; Eloy JO
Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242613
[TBL] [Abstract][Full Text] [Related]
18. The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer.
Alomrani A; Badran M; Harisa GI; ALshehry M; Alhariri M; Alshamsan A; Alkholief M
Saudi Pharm J; 2019 Jul; 27(5):603-611. PubMed ID: 31297013
[TBL] [Abstract][Full Text] [Related]
19. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil.
Cornwell PA; Barry BW
J Pharm Pharmacol; 1994 Apr; 46(4):261-9. PubMed ID: 8051608
[TBL] [Abstract][Full Text] [Related]
20. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
Safwat MA; Soliman GM; Sayed D; Attia MA
Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
